Search Within

Sloan Kettering Institute Postdocs

Formats
  1. Journal Article (8036)
  2. Meeting Abstract (3693)
  3. Review (630)
  4. Editorial (262)
  5. Book Section (195)
  6. Conference Paper (161)
  7. Research Letter (139)
  8. Correspondence (68)
  9. Miscellaneous (67)
  10. Guidelines (30)
  11. Book Whole (6)
Groups
  1. GSK Faculty (6363)
  2. Department of Medicine (4809)
  3. Sloan Kettering Institute Faculty (3570)
  4. Center for Molecular Imaging and Biotechnology (CMIB) (3037)
  5. Surgery (2633)
  6. Solid Tumor Oncology Division (2604)

More Groups

People
  1. Britta Weigelt (376)
  2. Jorge Reis-Filho (328)
  3. Mithat Gonen (318)
  4. Marc Ladanyi (309)
  5. Michael Berger (288)
  6. Joseph Deasy (285)

More People

Years
  1. 2026 (1)
  2. 2025 (697)
  3. 2024 (1080)
  4. 2023 (1152)
  5. 2022 (1366)
  6. 2021 (1179)

More Years

Publications
  1. Blood (680)
  2. Cancer Research (543)
  3. Journal of Clinical Oncology (431)
  4. Journal of Nuclear Medicine (271)
  5. Annals of Surgical Oncology (264)
  6. Clinical Cancer Research (249)

More Publications

Publishers
  1. Nature Publishing Group (1349)
  2. Elsevier Inc. (1106)
  3. American Association for Cancer Research (1058)
  4. Springer (840)
  5. American Society of Hematology (740)
  6. Cell Press (740)

More Publishers

Results (13287)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Frequent clinical overlap of histiocytic neoplasms and WHO-classified myeloid malignancies leads to functional insights into the cell-of-origin of histiocytoses
    Meeting Abstract

    Durham, B. H.; Yoshimi, A.; Papo, M.; Chung, Y. R.; Ozkaya, N.; Ganzel, C.; Dogan, A.; Hyman, D. M.; Park, C. Y.; Rampal, R. K.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Risk of bleeding in 9,429 patients with Philadelphia-negative myeloproliferative neoplasms: A population-based study from Sweden
    Meeting Abstract

    Creignou, M.; Bower, H.; Andersson, T. M. L.; Landtblom, A. R.; Dickman, P. W.; Björkholm, M.; Kristinsson, S. Y.; Hultcrantz, M.
    Blood (2016)

    Fulltext@MSK | Save
  • MYC-dependent PI3K and MCL-1 feedbacks attenuate BET inhibitors activity in diffuse large B-cell lymphoma
    Meeting Abstract

    Derenzini, E.; Mondello, P.; Liu, Y.; Scallion, M.; Asgari, Z.; Philip, J.; Hilden, P.; Djaballah, H.; Ouerfelli, O.; de Stanchina, E.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • An epigenetic regulator screen identifies novel targets that sensitize MLL-rearranged leukemia to DOT1L inhibition
    Meeting Abstract

    Chen, C. W. D.; Delaney, C.; Xu, H.; Koche, R.; Goizueta, A. L.; Hoshii, T.; Cusan, M.; Chabon, J.; Valerio, D. G.; Kuehn, M.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Aberrant phosphorylation of MEF2C is dispensable for hematopoiesis, and induces chemotherapy resistance and susceptibility to MARK kinase inhibition therapy in acute myeloid leukemia
    Meeting Abstract

    Brown, F. C.; Still, E.; Cifani, P.; Reed, C.; Ficarro, S.; He, J.; Koche, R.; Bhola, P.; Romanienko, P.; Mark, W.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • The preclinical efficacy of a novel telomerase inhibitor, imetelstat, in AML - A randomized trial in patient-derived xenografts
    Meeting Abstract

    Bruedigam, C.; Wackrow, B.; Song, A.; Porter, A. H.; Lee, S. C. W.; Moore, A. S.; Abdel-Wahab, O.; Lane, S. W.
    Blood (2016)

    Fulltext@MSK | Save
  • H3B-8800, an orally bioavailable modulator of the SF3b complex, shows efficacy in spliceosome-mutant myeloid malignancies
    Meeting Abstract

    Buonamici, S.; Yoshimi, A.; Thomas, M.; Seiler, M.; Chan, B.; Caleb, B.; Darman, R.; Fekkes, P.; Karr, C.; Keaney, G. F.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • IL-18 secreting CAR T cells enhance cell persistence, induce prolonged B cell aplasia and eradicate CD19+ tumor cells without need for prior conditioning
    Meeting Abstract

    Avanzi, M. P.; van Leeuwen, D. G.; Li, X.; Cheung, K.; Park, H.; Purdon, T. J.; Brentjens, R. J.
    Blood (2016)

    Fulltext@MSK | Save
  • 3' untranslated region (UTR) alterations are frequently targeted by MM-related miRNAs and affects the clinical outcome
    Meeting Abstract

    Samur, M. K.; Singh, I.; Shih-Han, L.; Sperling, A. S.; Fulciniti, M.; Tai, Y. T.; Parmigiani, G.; Leslie, C. S.; Mayr, C.; Munshi, N. C.
    Blood (2016)

    Fulltext@MSK | Save
  • Markers for increased thrombotic risk within the complete blood count
    Meeting Abstract

    Rognvaldsson, S.; Lund, S. H.; Hultcrantz, M.; Sveinsdottir, S. V.; Eiriksdottir, G.; Harris, T. B.; Guonason, V.; Kristinsson, S. Y.
    Blood (2016)

    Fulltext@MSK | Save